[HTML][HTML] Gram-negative neonatal sepsis in low-and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta …

SCH Wen, Y Ezure, L Rolley, G Spurling, CL Lau… - PLoS …, 2021 - journals.plos.org
Background Neonatal sepsis is a significant global health issue associated with marked
regional disparities in mortality. Antimicrobial resistance (AMR) is a growing concern in …

Reviewing the WHO guidelines for antibiotic use for sepsis in neonates and children

A Fuchs, J Bielicki, S Mathur, M Sharland… - Paediatrics and …, 2018 - Taylor & Francis
Background Guidelines from 2005 for treating suspected sepsis in low-and middle-income
countries (LMIC) recommended hospitalisation and prophylactic intramuscular (IM) or …

[HTML][HTML] Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis …

NJ Russell, W Stöhr, N Plakkal, A Cook… - PLoS …, 2023 - journals.plos.org
Background There is limited data on antibiotic treatment in hospitalized neonates in low-and
middle-income countries (LMICs). We aimed to describe patterns of antibiotic use …

[HTML][HTML] Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study

SK Saha, SJ Schrag, S El Arifeen, LC Mullany… - The Lancet, 2018 - thelancet.com
Background More than 500 000 neonatal deaths per year result from possible serious
bacterial infections (pSBIs), but the causes are largely unknown. We investigated the …

Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin–clavulanic acid) versus a full course of intravenous antibiotics in neonates with …

FM Keij, RF Kornelisse, NG Hartwig… - The Lancet Child & …, 2022 - thelancet.com
Background Switching from intravenous antibiotic therapy to oral antibiotic therapy among
neonates is not yet practised in high-income settings due to uncertainties about exposure …

Antibiotic regimens for late‐onset neonatal sepsis

SK Korang, S Safi, C Nava, G Greisen… - Cochrane Database …, 2021 - cochranelibrary.com
Background Neonatal sepsis is a major cause of morbidity and mortality. It is the third
leading cause of neonatal mortality globally constituting 13% of overall neonatal mortality …

[HTML][HTML] Managing possible serious bacterial infection of young infants where referral is not possible: Lessons from the early implementation experience in Kushtia …

AE Rahman, S Herrera, S Rubayet, G Banik, R Hasan… - PloS one, 2020 - journals.plos.org
Background Serious infections account for 25% of global newborn deaths annually, most in
low-resource settings where hospital-based treatment is not accessible or feasible. In …

Antibiotic regimens for early‐onset neonatal sepsis

SK Korang, S Safi, C Nava, A Gordon… - Cochrane Database …, 2021 - cochranelibrary.com
Background Neonatal sepsis is a major cause of morbidity and mortality. It is the third
leading cause of neonatal mortality globally constituting 13% of overall neonatal mortality …

[HTML][HTML] WHO's essential medicines and AWaRe: recommendations on first-and second-choice antibiotics for empiric treatment of clinical infections

L Moja, V Zanichelli, D Mertz, S Gandra… - Clinical Microbiology …, 2024 - Elsevier
Abstract The WHO Model List of Essential Medicines (EML) prioritizes medicines that have
significant global public health value. The EML can also deliver important messages on …

[HTML][HTML] Lessons from implementation research on community management of Possible Serious Bacterial Infection (PSBI) in young infants (0-59 days), when the …

R Mukhopadhyay, NK Arora, PK Sharma, S Dalpath… - PloS one, 2021 - journals.plos.org
Background Neonatal sepsis is a major cause of death in India, which needs hospital
management but many families cannot access hospitals. The World Health Organization …